Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Yerkes, R. M., and Yerkes, A. W., The Great Apes. A Study of Anthropoid Life (Yale Univ. Press, New Haven, 1929).

David Lumb is a managing editor for the mobile team, covering mobile and gaming spaces. Over the last decade, he's reviewed phones for TechRadar as well as covered tech, gaming, and culture for ...

When it comes to using AI, it seems lawyers just can't help themselves. Last year saw a rapid increase in court sanctions against attorneys for filing briefs containing errors generated by artificial ...